EzaLife has entered the final days of its equity crowdfunding campaign on StartEngine, with the raise set to close on April 6. The company, which developed the FDA-registered Button Huggie® device, is addressing a critical issue impacting over 1 million families annually who rely on feeding tubes. Founded by a pediatric surgeon who witnessed firsthand the limitations of traditional securement methods, EzaLife has built a solution focused on simplicity, safety, and reliability.
Key highlights from the campaign include a clinically demonstrated 77% reduction in feeding tube dislodgement, early traction with $8,000 in pre-orders and $11,000 in first-month sales, and backing from leading institutions such as Children’s Hospital Colorado and CU Innovations. The company has also secured granted patents with global protection and a future pipeline potential. With momentum building across both clinical and consumer channels, EzaLife is now focused on scaling distribution and expanding access to patients and providers.
“This is a pivotal moment for the company,” leadership noted in the release. “We’ve built the foundation, now we’re focused on growth.” The campaign’s closing represents a limited window for investors to participate before the offering ends. The Button Huggie® device directly addresses a critical gap in medical care, where feeding tube dislodgement can lead to emergency room visits, hospital readmissions, and increased healthcare costs. EzaLife’s solution not only improves patient outcomes but also reduces the burden on healthcare systems.
As the company moves from early traction to scaling, the capital raised will support expanded manufacturing, sales efforts, and further clinical validation. The backing from Children’s Hospital Colorado and CU Innovations underscores the device’s potential to become a standard of care. For families and providers, the Button Huggie® offers a simple, secure method to prevent accidental tube removal, giving peace of mind to caregivers and patients alike.
The implications of this announcement are significant for the medical device industry and for the millions of patients dependent on feeding tubes. EzaLife’s success in crowdfunding could pave the way for broader adoption of its technology, potentially reducing healthcare costs and improving quality of life. As the campaign enters its final days, the company is poised to leverage this momentum to bring its solution to a wider market, addressing a long-standing unmet need in patient care.
